| Nicholas Jay Moore, MD | |
|
26850 Providence Pkwy Ste 260, Novi, MI 48374-1256 | |
| (248) 465-5140 | |
| (248) 465-5141 |
| Full Name | Nicholas Jay Moore |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 13 Years |
| Location | 26850 Providence Pkwy Ste 260, Novi, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265727556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301108292 (Michigan) | Secondary |
| 207QS0010X | Family Medicine - Sports Medicine | 4301108292 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Huron Valley-sinai Hospital | Commerce township, MI | Hospital |
| Ascension St John Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Providence Hospital | 6103738703 | 181 |
News Archive
Researchers say that there should be a greater emphasis on preventing cardiovascular disease in people with asthma after finding that it was the leading cause of death in hospitalized asthma patients.
PDI, Inc., today reported financial and operational results for the third quarter ended September 30, 2011.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
Research from the Norwegian Institute of Public Health (NIPH) shows that children with severe congenital heart defects have twice the risk of anxiety at 18 months of age compared to healthy children. Children with mild and moderate heart defects, on the other hand, did not show an increased risk of anxiety.
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
› Verified 4 days ago
| Entity Name | Ascension Providence Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942265236 PECOS PAC ID: 6103738703 Enrollment ID: O20031103000326 |
News Archive
Researchers say that there should be a greater emphasis on preventing cardiovascular disease in people with asthma after finding that it was the leading cause of death in hospitalized asthma patients.
PDI, Inc., today reported financial and operational results for the third quarter ended September 30, 2011.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
Research from the Norwegian Institute of Public Health (NIPH) shows that children with severe congenital heart defects have twice the risk of anxiety at 18 months of age compared to healthy children. Children with mild and moderate heart defects, on the other hand, did not show an increased risk of anxiety.
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
› Verified 4 days ago
| Entity Name | Vhs Physicians Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073827101 PECOS PAC ID: 8921289760 Enrollment ID: O20110225000849 |
News Archive
Researchers say that there should be a greater emphasis on preventing cardiovascular disease in people with asthma after finding that it was the leading cause of death in hospitalized asthma patients.
PDI, Inc., today reported financial and operational results for the third quarter ended September 30, 2011.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
Research from the Norwegian Institute of Public Health (NIPH) shows that children with severe congenital heart defects have twice the risk of anxiety at 18 months of age compared to healthy children. Children with mild and moderate heart defects, on the other hand, did not show an increased risk of anxiety.
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Jay Moore, MD 26850 Providence Pkwy Ste 260, Novi, MI 48374-1256 Ph: (248) 465-5140 | Nicholas Jay Moore, MD 26850 Providence Pkwy Ste 260, Novi, MI 48374-1256 Ph: (248) 465-5140 |
News Archive
Researchers say that there should be a greater emphasis on preventing cardiovascular disease in people with asthma after finding that it was the leading cause of death in hospitalized asthma patients.
PDI, Inc., today reported financial and operational results for the third quarter ended September 30, 2011.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
Research from the Norwegian Institute of Public Health (NIPH) shows that children with severe congenital heart defects have twice the risk of anxiety at 18 months of age compared to healthy children. Children with mild and moderate heart defects, on the other hand, did not show an increased risk of anxiety.
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
› Verified 4 days ago
Robert A Carter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 26850 Providence Pkwy, Suite 375, Novi, MI 48374 Phone: 248-662-4200 Fax: 248-662-0368 | |
Victoria Nicole Dooley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21580 Novi Rd, Ste 200, Novi, MI 48375 Phone: 248-946-4905 | |
Thomas Joseph Anan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 25691 Strath Haven Dr, Novi, MI 48374 Phone: 586-256-4170 Fax: 248-465-4901 | |
Michael Balon, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 26850 Providence Pkwy, Suite 370, Novi, MI 48374 Phone: 248-465-4160 Fax: 248-465-4525 | |
Moneer Al-nabolsi, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44130 W 12 Mile Rd, Novi, MI 48377 Phone: 248-380-8811 | |
Dr. Jeffrey Joshowitz, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 39475 Lewis Dr, Suite 140, Novi, MI 48377 Phone: 248-489-0766 Fax: 248-489-0788 | |
Dr. Bilal Tarek Malek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 39555 Orchard Hill Pl Ste 600, Novi, MI 48375 Phone: 248-621-4581 Fax: 248-621-4582 |